HealthQuill US
Migratory flows have fanned the Chagas disease, and a study of 2,820 people from the countries where it is an endemic, revealed that 47% were infected by the parasite and 17% had heart lesions.
Health Medical Pharma

Migration leading to high global prevalence of Chagas disease

HQ Team July 17, 2023: Migratory flows have fanned the Chagas disease, and a study of 2,820 people from the countries where it.

Read More
About 316 new cases of pox and two deaths have been reported to the WHO since June 24, with a significant rise of the disease in the South-East Asian region, mainly Thailand.
Drugs Health Pharma

Mpox cases on the rise globally, Thailand is the new hotspot

 HQ Team July 15, 2023: About 316 new cases of mpox and two deaths have been reported to the WHO since June 24,.

Read More
About 45% of the US tap water contains one or more types of   “forever chemicals,” found in the linings of fast-food boxes and non-stick cookware to fire-fighting foams, raising health concerns, according to a US Geological Survey study.
Drugs Health Pharma

In US, 48% of tap water contains ‘forever chemicals’: Geological Survey

HQ Team July 7, 2023: About 45% of the US tap water contains one or more types of   “forever chemicals,” found in.

Read More
American beekeepers lost nearly half of their managed colonies even as honeybee hives buzzed through their second-highest death rate on record to remain “relatively stable,” according to Bee Informed Partnership.
Climate Health Pharma

US beekeepers lose half of managed colonies, hives death rate rise

HQ Team June 28: 2023: American beekeepers lost nearly half of their managed colonies even as honeybee hives buzzed through their second-highest death.

Read More
For the first time in 20 years, locally-acquired cases of malaria have been detected in two US states, Florida and Texas, according to the Centres for Disease Control and Prevention.
Drugs Health Pharma

US issues advisory as locally acquired malaria resurfaces after 20 years 

HQ Team June 27, 2023: For the first time in 20 years, locally-acquired cases of malaria have been detected in two US states,.

Read More
The USFDA has approved Pfizer Inc’s oral Talzenna drug in combination with Xtandi to treat advanced prostate cancer in adult patients, according to a statement.
Drugs Health Pharma

Pfizer gets FDA nod for combination drug to treat advanced prostate cancer

HQ Team June 21, 2023: The USFDA has approved Pfizer Inc’s oral Talzenna drug in combination with Xtandi to treat advanced prostate cancer.

Read More
Indian pharmaceutical company, Lupin Limited, has introduced its thiamine injection in the US market and has got FDA’s   ‘no action required’ classification for its domestic facility in the country’s south.
Drugs Health Pharma Uncategorized

India’s Lupin unveils thiamine injection in US, receives FDA’s NAR for Vizag unit

HQ Team June 20, 2023: Indian pharmaceutical company, Lupin Limited, has introduced its thiamine injection in the US market and has got FDA’s.

Read More
Valneva SE, a French vaccine maker, announced that its last-stage trials for its single-shot chikungunya registered a 98.9% vaccination success rate.
Drugs Medical Pharma

France’s Valneva says trial vaccine for chikungunya post 98.9% rate

HQ Team June 13, 2023: Valneva SE, a French vaccine maker, announced that its last-stage trials for its single-shot chikungunya registered a 98.9%.

Read More
Swiss drugmaker, Novartis signed a $3.5 billion deal with Chinook Therapeutics to boost the US-based company’s last-stage experimental trials of two drugs to treat chronic kidney diseases.
Drugs Health Pharma

Novartis to acquire Chinook Therapeutics in a $3.5 billion deal

HQ Team June 13, 2023: Swiss drugmaker, Novartis signed a $3.5 billion deal with Chinook Therapeutics to boost the US-based company’s last-stage experimental.

Read More
AstraZeneca, a British-Swedish pharmaceutical company, has signed a deal, worth more than $2 billion, with Quell Therapeutics to develop cell therapies for treating autoimmune diseases.
Drugs Health Pharma

AstraZeneca signs $2 billion deal for autoimmune diseases

HQ Team June 9, 2023: AstraZeneca, a British-Swedish pharmaceutical company, has signed a deal, worth more than $2 billion, with Quell Therapeutics to.

Read More